APA citiranje

Kantarjian, H. M., Silver, R. T., Komrokji, R. S., Mesa, R. A., Tacke, R., & Harrison, C. N. (2013). Ruxolitinib for Myelofibrosis – An Update of Its Clinical Effects. Clin Lymphoma Myeloma Leuk.

Citação norma Chicago

Kantarjian, Hagop M., Richard T. Silver, Rami S. Komrokji, Ruben A. Mesa, Roland Tacke, and Claire N. Harrison. "Ruxolitinib for Myelofibrosis – An Update of Its Clinical Effects." Clin Lymphoma Myeloma Leuk 2013.

MLA citiranje

Kantarjian, Hagop M., et al. "Ruxolitinib for Myelofibrosis – An Update of Its Clinical Effects." Clin Lymphoma Myeloma Leuk 2013.